The Commission has authorised the Spikevax XBB.1.5-adapted COVID-19 vaccine, developed by Moderna. This is another important step in the fight against the disease. It is the third adaptation of this vaccine to respond to new COVID-19 variants. The European Medicines Agency (EMA) carried out a stringent evaluation of the vaccine under the accelerated assessment mechanism. Following this […]
Booster dose for people over 40 years old, elderly and vulnerable people – COVID-19
The European Centre for Disease Prevention and Control (ECDC) has issued a new report, in which it considers that the third dose should be applied 6 months after receiving the full course. The European Centre for Disease Prevention and Control (ECDC) has issued a new report, which assesses the risk of the population to […]